BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 9314617)

  • 1. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease.
    Carp JM; Onuma E; Das K; Gottlieb AB
    Cutis; 1997 Sep; 60(3):135-8. PubMed ID: 9314617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous cyclosporine in refractory pyoderma gangrenosum complicating inflammatory bowel disease.
    Friedman S; Marion JF; Scherl E; Rubin PH; Present DH
    Inflamm Bowel Dis; 2001 Feb; 7(1):1-7. PubMed ID: 11233655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: Triple Combination Therapy for Recalcitrant Perineal Pyoderma Gangrenosum.
    Shaath TS; Om A; Wolfe CM; Cohen GF
    J Drugs Dermatol; 2019 Mar; 18(3):307-310. PubMed ID: 31020825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical tacrolimus (FK506) in the treatment of recalcitrant parastomal pyoderma gangrenosum associated with Crohn's disease: report of two cases.
    Khurrum Baig M; Marquez H; Nogueras JJ; Weiss EG; Wexner SD
    Colorectal Dis; 2004 Jul; 6(4):250-3. PubMed ID: 15206967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pyoderma gangrenosum, a nonintestinal manifestation of Lesniowski-Crohn's disease in a 15 years old girl].
    Müller L; Bala G; Kuczyńska R; Czerwionka-Szaflarska M
    Med Wieku Rozwoj; 2006; 10(2):463-73. PubMed ID: 16825717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel therapy for the treatment of pyoderma gangrenosum.
    Azizan NZ; Gangaram HB; Hussein SH
    Med J Malaysia; 2008 Mar; 63(1):51-4. PubMed ID: 18935734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of pyoderma gangrenosum with cyclosporine.
    Matis WL; Ellis CN; Griffiths CE; Lazarus GS
    Arch Dermatol; 1992 Aug; 128(8):1060-4. PubMed ID: 1497359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyoderma gangrenosum as initial manifestation of Graves' disease.
    Livideanu C; Lipsker D; Paul C; Juillard J; Schubert B
    Clin Exp Dermatol; 2006 Sep; 31(5):659-61. PubMed ID: 16780496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical outcome following treatment of refractory inflammatory and fistulizing Crohn's disease with intravenous cyclosporine.
    Egan LJ; Sandborn WJ; Tremaine WJ
    Am J Gastroenterol; 1998 Mar; 93(3):442-8. PubMed ID: 9517654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infliximab for treatment of pyoderma gangrenosum associated with clinically inactive Crohn's disease. A case report.
    Kouklakis G; Moschos J; Leontiadis GI; Kadis S; Mpoumponaris A; Molyvas E; Minopoulos GI
    Rom J Gastroenterol; 2005 Dec; 14(4):401-3. PubMed ID: 16400359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extraintestinal manifestations of Crohn's disease.
    Juillerat P; Mottet C; Froehlich F; Felley C; Vader JP; Burnand B; Gonvers JJ; Michetti P
    Digestion; 2005; 71(1):31-6. PubMed ID: 15711047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cyclosporin A therapy in steroid-refractory patients with chronic inflammatory bowel diseases].
    Dejaco C; Gasché C; Reinisch W; Moser G; Novacek G; Tillinger W; Vogelsang H; Gangl A
    Wien Klin Wochenschr; 1998 Sep; 110(16):579-84. PubMed ID: 9782579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of postoperative pyoderma gangrenosum with cyclosporin.
    Schöfer H; Baur S
    J Eur Acad Dermatol Venereol; 2002 Mar; 16(2):148-51. PubMed ID: 12046819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated healing of pyoderma gangrenosum in Behçet patient treated with cyclosporine and split thickness skin graft.
    Kim DW; Lee BI; Park SH
    Ann Plast Surg; 2008 Nov; 61(5):552-4. PubMed ID: 18948785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory pyoderma gangrenosum of the orbit and the lacrimal sac.
    Cordero-Coma M; Pérez-Moreiras JV; Toribio A; Alonso-Orcajo N; Calleja S; Franco M; Ruiz de Morales JG
    Orbit; 2012 Aug; 31(4):249-51. PubMed ID: 22571540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical pyoderma gangresosum in inflammatory bowel disease. A severe diagnostic challenge.
    Muñoz PS; Ugidos AF; Montiel PM; Yagüe TM; Garrido C; Herruzo JA
    Rev Esp Enferm Dig; 2009 Aug; 101(8):585-7. PubMed ID: 19785502
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical features and management of parastomal pyoderma gangrenosum in inflammatory bowel disease.
    Uchino M; Ikeuchi H; Matsuoka H; Bando T; Takahashi Y; Takesue Y; Matsumoto T; Tomita N
    Digestion; 2012; 85(4):295-301. PubMed ID: 22584791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease.
    Regueiro M; Valentine J; Plevy S; Fleisher MR; Lichtenstein GR
    Am J Gastroenterol; 2003 Aug; 98(8):1821-6. PubMed ID: 12907338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.